CLINICAL_TRIALS
trial_result
· 2023-06-09
Clinical Trial Update: A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis [Phase 2]
Summary
Phase 2 trial update for topical azelaic acid 15% in treating mild to moderate perioral dermatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Perioral Dermatitis | Phase 2 | Status: COMPLETED